Charlton, Thomas G <br/><br/>
The impact of HIV infection and antiretroviral therapy on the predicted risk of Down syndrome.  [electronic resource] 

 -  Prenatal diagnosis  Feb 2014 
 - 121-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1097-0223 
<br/><br/><label>Standard No.: </label>10.1002/pd.4267  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--therapeutic use<br/>Antiretroviral Therapy, Highly Active<br/>Black People<br/>CD4 Lymphocyte Count<br/>Case-Control Studies<br/>Chorionic Gonadotropin, beta Subunit, Human--blood<br/>Down Syndrome--blood<br/>Estriol--blood<br/>Female<br/>HIV Infections--blood<br/>Humans<br/>London--epidemiology<br/>Maternal Age<br/>Pregnancy<br/>Pregnancy Complications, Infectious--blood<br/>Pregnancy Trimester, Second--metabolism<br/>Prenatal Diagnosis<br/>RNA, Viral--blood<br/>Risk Assessment<br/>Viral Load<br/>White People<br/>Young Adult<br/>alpha-Fetoproteins--metabolism